As antibody response reflects host immune function, we hypothesize that antibody titers to periodontal bacteria may complement plasma TNF-α levels in improving the clinical diagnosis of AD patients and differentiate them from cognitively normal subjects (47, 49). The gene discussed is TNF; the disease is Alzheimer disease.